| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.022 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |